foxo4 dri peptide senolytic 2024 study

foxo4 dri peptide senolytic 2024 study FOXO4-DRI Molecular modelling of the FOXO4-TP53

Name: foxo4 dri peptide senolytic 2024 study FOXO4-DRI Molecular modelling of the FOXO4-TP53
Brand: www.asociacionchamorro.org
SKU: 64553733549
Price: 26.62 USD
Availability: InStock
Rating: 4.0936 (20 reviews)

Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv

SKU: 64553733549 · From www.asociacionchamorro.org

4.1

USD26.62 USD70.62

Pay in 4 interest-free payments of $6.66 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

Description

Copper deficiency compromises cuproenzyme function, causing mitochondrial dysfunction (via impaired CCO), reduced antioxidant defense (via SOD downregulation), and structural defects (via reduced LOX activity leading to fibrosis)

Epithalon injected to rats exposed to any photoregimen also significantly inhibited the development of spontaneous tumors, primarily testicular leydigomas and leukemias